D. de Boer

发表

Survival after massive ecstasy overdose.

J. Beijnen, R. Maes, P. Meenhorst, 1998, Journal of toxicology. Clinical toxicology.

Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.

I. Bosman, R. Maes, D. de Boer, 2001, Forensic science international.

CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA).

F. Oesch, F. Carvalho, J. Hengstler, 2007, Toxicology.

Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis.

J. Thijssen, R. Maes, D. de Boer, 2000, Journal of analytical toxicology.

Doping Control of Testosterone and Human Chorionic Gonadotrophin: A Case Study

J. V. van Rossum, R. Maes, D. de Boer, 1991, International journal of sports medicine.

Seizure of illicitly produced para-fluorofentanyl: quantitative analysis of the content of capsules and tablets.

R. Maes, D. de Boer, W. Goemans, 2003, Journal of pharmaceutical and biomedical analysis.

Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration.

F. Carvalho, M. de Lourdes Bastos, F. Remião, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs

I. Bosman, D. de Boer, 2004, Pharmacy World and Science.

Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry.

E. D. de Bruijn, R. Maes, J. J. Kettenes-van den Bosch, 1997, Journal of mass spectrometry : JMS.

The analysis of trenbolone and the human urinary metabolites of trenbolone acetate by gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry.

R. Maes, D. de Boer, M. E. Gainza Bernal, 1991, Biological mass spectrometry.

Artifact formation due to ethyl thio-incorporation into silylated steroid structures as determined in doping analysis.

J. Thijssen, R. Fokkens, N. Nibbering, 2002, Journal of chromatography. A.

Enantioselective quantitation of (R)- and (S)-alprenolol by gas chromatography-mass spectrometry in human saliva an plasma.

J. Zuidema, R. Maes, D. de Boer, 1996, Journal of chromatographic science.

The detection of danazol and its significance in doping analysis.

R. Maes, D. de Boer, E. de Jong, 1992, Journal of analytical toxicology.

Mass spectrometric characterization of different norandrosterone derivatives by low-cost mass spectrometric detectors using electron ionization and chemical ionization.

R. Maes, D. de Boer, E. de Jong, 1990, Rapid communications in mass spectrometry : RCM.

Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.

F. Oesch, E. Fernandes, F. Carvalho, 2005, Toxicology.

Identification of 4-methylthioamphetamine and some of its metabolites in mouse urine by GC-MS after acute administration.

F. Carvalho, F. Remião, M. Bastos, 2002, Journal of analytical toxicology.

Determination of furosemide in whole blood using SPE and GC-EI-MS.

E. Gallardo, M. Barroso, D. de Boer, 2005, Journal of analytical toxicology.

The problems of oral contraceptives in dope control of anabolic steroids.

J. V. van Rossum, R. Maes, D. de Boer, 1988, Biomedical & environmental mass spectrometry.

Quantitation of 11 -nor-delta9-tetrahydrocannabinol-9-carboxylic acid with GC-MS in urine collected for doping analysis.

P. Van Eenoo, D. de Boer, K. D. De Cock, 2003, Journal of analytical toxicology.

More data about the new psychoactive drug 2C-B.

I. Bosman, R. Maes, D. de Boer, 1999, Journal of Analytical Toxicology.

4-Methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways.

E. Fernandes, F. Carvalho, M. de Lourdes Bastos, 2003, Toxicology and applied pharmacology.